Several studies indicate that ER may be implicated in breast cancer cell survival via cross-talk with the PI3K/Akt pathway [31], or by regulating the activity of NF-κB [32,33], Bcl-2 [34,35], or IAP family members [36]. The gene discussed is NFKB1; the disease is breast carcinoma.